Tekmira Pharmaceuticals Corporation Provides Corporate Update And Announces Year-End 2013 Results

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

VANCOUVER, British Columbia, March 6, 2014 (GLOBE NEWSWIRE) -- Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, announced today its 2013 audited financial results and provided a corporate update.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC